4
Changes in Ownership
MapLight Therapeutics, Inc. Filed Acc 0001728746-26-000012
Chief Scientific Officer sold 18,267 shares at an average $36.88 ($673,636)
From the SEC's structured data for this filing
Trades in this filing
Lillie James Woodruff · Chief Scientific Officer
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-07-15 | Sale : show line 1 in the form | −2,238 | $36.00 | $80,568 | 240,491 | D |
| 2026-07-15 | Sale : show line 2 in the form | −5,393 | $36.99 | $199,487 | 235,098 | D |
| 2026-07-15 | Sale : show line 3 in the form | −12 | $37.54 | $450 | 235,086 | D |
| 2026-07-16 | Sale : show line 4 in the form | −5,009 | $36.45 | $182,578 | 230,077 | D |
| 2026-07-16 | Sale : show line 5 in the form | −3,526 | $37.26 | $131,379 | 226,551 | D |
| 2026-07-16 | Sale : show line 6 in the form | −12 | $37.96 | $456 | 226,539 | D |
| 2026-07-17 | Sale : show line 7 in the form | −2,077 | $37.90 | $78,718 | 224,462 | D |
| Open-market sales · 18,267 sh · avg $36.88 · $673,636 | ||||||
Loading xslF345X06/form4-07182026_010728.xml…